Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v5-EN
Language French English
Date Updated 2020-02-13 2020-02-13
Drug Identification Number 02239365 02239365
Brand name RATIO-SALBUTAMOL RATIO-SALBUTAMOL
Common or Proper name SALBUTAMOL SALBUTAMOL
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients SALBUTAMOL SALBUTAMOL
Strength(s) 0.5MG 0.5MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INHALATION INHALATION
Packaging size 20 x 2.5ML 20 x 2.5ML
ATC code R03AC R03AC
ATC description ADRENERGICS, INHALANTS ADRENERGICS, INHALANTS
Reason for shortage Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2016-11-01 2016-11-01
Estimated end date
Actual end date 2017-06-15 2017-06-15
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments Product Discontinued. Product Discontinued.
Health Canada comments